ONC
The table below shows BeOne Medicines AG's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.79B | $4.04B | $2.76B | $2.52B | $2.70B | $2.59B |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $938.02M | $863.28M | $770.78M | $717.24M | $569.05M | $529.45M |
| Inventory | $681.59M | $531.69M | $502.87M | $494.66M | $431.68M | $443.26M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $6.60B |
| $5.66B |
| $4.31B |
| $3.90B |
| $3.91B |
| $3.84B |
| Property, plant & equipment | $1.64B | $1.63B | $1.62B | $1.60B | $1.56B | $1.52B |
| Goodwill | - | - | - | - | - | - |
| Total assets | $8.55B | $7.63B | $6.30B | $5.84B | $5.83B | $5.71B |
| Accounts payable | $423.55M | $383.68M | $360.78M | $364.50M | $307.53M | $333.02M |
| Total current liabilities | $1.81B | $2.37B | $2.21B | $1.98B | $2.03B | $1.94B |
| Long-term debt | $962.51M | - | $146.09M | $160.16M | $187.51M | $185.27M |
| Total liabilities | $3.79B | $3.50B | $2.53B | $2.34B | $2.39B | $2.35B |
| Retained earnings | -$8.09B | -$8.39B | -$8.51B | -$8.61B | -$8.45B | -$8.33B |
| Total equity | $4.76B | $4.13B | $3.77B | $3.50B | $3.44B | $3.37B |